v3.26.3
Revenue Recognition and Accounts Receivable - Schedule of Net Sales by Product Category and Reporting Segment (Detail) - USD ($)
$ in Thousands
 3 Months Ended 9 Months Ended
Sep. 30, 2026
Sep. 30, 2025
Sep. 30, 2026
Sep. 30, 2025
Revenue Recognition And Accounts Receivable [Line Items]        
Net sales $ 207,862 $ 205,634 $ 615,503 $ 602,401
Change 1.10%   2.20%  
Therapeutic Solutions [Member]        
Revenue Recognition And Accounts Receivable [Line Items]        
Net sales $ 63,956 61,211 $ 185,882 178,834
Change 4.50%   3.90%  
Spinal Implants, Biologics, and Enabling Technologies [Member]        
Revenue Recognition And Accounts Receivable [Line Items]        
Net sales $ 107,493 110,852 $ 322,662 326,889
Change 3.00%   1.30%  
Global Spine [Member]        
Revenue Recognition And Accounts Receivable [Line Items]        
Net sales $ 171,449 172,063 $ 508,544 505,723
Change 0.40%   0.60%  
Global Limb Reconstruction [Member]        
Revenue Recognition And Accounts Receivable [Line Items]        
Net sales $ 36,413 $ 33,571 $ 106,959 $ 96,678
Change 8.50%   10.60%